143 related articles for article (PubMed ID: 29247465)
1. Cannabinoid-glutamate interactions and neural oscillations: implications for psychosis.
Sherif MA; Cortes-Briones JA; Ranganathan M; Skosnik PD
Eur J Neurosci; 2018 Oct; 48(8):2890-2902. PubMed ID: 29247465
[TBL] [Abstract][Full Text] [Related]
2. The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases.
Sánchez-Blázquez P; Rodríguez-Muñoz M; Herrero-Labrador R; Burgueño J; Zamanillo D; Garzón J
Int J Neuropsychopharmacol; 2014 Dec; 17(12):1943-55. PubMed ID: 24485144
[TBL] [Abstract][Full Text] [Related]
3. It's All in the Rhythm: The Role of Cannabinoids in Neural Oscillations and Psychosis.
Skosnik PD; Cortes-Briones JA; Hajós M
Biol Psychiatry; 2016 Apr; 79(7):568-77. PubMed ID: 26850792
[TBL] [Abstract][Full Text] [Related]
4. Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophrenia.
McNally JM; McCarley RW; McKenna JT; Yanagawa Y; Brown RE
Neuroscience; 2011 Dec; 199():51-63. PubMed ID: 22027237
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission.
Domenici MR; Azad SC; Marsicano G; Schierloh A; Wotjak CT; Dodt HU; Zieglgänsberger W; Lutz B; Rammes G
J Neurosci; 2006 May; 26(21):5794-9. PubMed ID: 16723537
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans.
Skosnik PD; Hajós M; Cortes-Briones JA; Edwards CR; Pittman BP; Hoffmann WE; Sewell AR; D'Souza DC; Ranganathan M
Neuropharmacology; 2018 Jun; 135():412-423. PubMed ID: 29604295
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate.
Sánchez-Blázquez P; Rodríguez-Muñoz M; Vicente-Sánchez A; Garzón J
Antioxid Redox Signal; 2013 Nov; 19(15):1766-82. PubMed ID: 23600761
[TBL] [Abstract][Full Text] [Related]
8. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain.
Marsicano G; Lutz B
Eur J Neurosci; 1999 Dec; 11(12):4213-25. PubMed ID: 10594647
[TBL] [Abstract][Full Text] [Related]
9. HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity.
Vicente-Sánchez A; Sánchez-Blázquez P; Rodríguez-Muñoz M; Garzón J
Mol Brain; 2013 Oct; 6():42. PubMed ID: 24093505
[TBL] [Abstract][Full Text] [Related]
10. Human Laboratory Studies on Cannabinoids and Psychosis.
Sherif M; Radhakrishnan R; D'Souza DC; Ranganathan M
Biol Psychiatry; 2016 Apr; 79(7):526-38. PubMed ID: 26970363
[TBL] [Abstract][Full Text] [Related]
11. Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study.
Borgan F; Veronese M; Reis Marques T; Lythgoe DJ; Howes O
Eur Arch Psychiatry Clin Neurosci; 2021 Jun; 271(4):677-687. PubMed ID: 32986150
[TBL] [Abstract][Full Text] [Related]
12. Striatal GABAergic and cortical glutamatergic neurons mediate contrasting effects of cannabinoids on cortical network synchrony.
Sales-Carbonell C; Rueda-Orozco PE; Soria-Gómez E; Buzsáki G; Marsicano G; Robbe D
Proc Natl Acad Sci U S A; 2013 Jan; 110(2):719-24. PubMed ID: 23269835
[TBL] [Abstract][Full Text] [Related]
13. Thalamo-cortical communication, glutamatergic neurotransmission and neural oscillations: A unique window into the origins of ScZ?
Pratt J; Dawson N; Morris BJ; Grent-'t-Jong T; Roux F; Uhlhaas PJ
Schizophr Res; 2017 Feb; 180():4-12. PubMed ID: 27317361
[TBL] [Abstract][Full Text] [Related]
14. The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia.
Sánchez-Blázquez P; Rodríguez-Muñoz M; Garzón J
Front Pharmacol; 2014 Jan; 4():169. PubMed ID: 24427139
[TBL] [Abstract][Full Text] [Related]
15. Local NMDA receptor hypofunction evokes generalized effects on gamma and high-frequency oscillations and behavior.
Lee J; Hudson MR; O'Brien TJ; Nithianantharajah J; Jones NC
Neuroscience; 2017 Sep; 358():124-136. PubMed ID: 28676240
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids and psychosis.
D'Souza DC
Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
[TBL] [Abstract][Full Text] [Related]
17. MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors.
Irie T; Kikura-Hanajiri R; Usami M; Uchiyama N; Goda Y; Sekino Y
Neuropharmacology; 2015 Aug; 95():479-91. PubMed ID: 25747605
[TBL] [Abstract][Full Text] [Related]
18. NAAG, NMDA receptor and psychosis.
Bergeron R; Coyle JT
Curr Med Chem; 2012; 19(9):1360-4. PubMed ID: 22304714
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of Schizophrenia.
Treder N; Martínez-Pinteño A; Rodríguez N; Arbelo N; Madero S; Gómez M; García-Rizo C; Mas S; Gassó P; Parellada E; Morén C
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674542
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid-glutamate interactions in the regulation of food intake in neonatal layer- type chicks: role of glutamate NMDA and AMPA receptors.
Keyshams N; Zendehdel M; Babapour V; Baghbanzadeh A
Vet Res Commun; 2016 Jun; 40(2):63-71. PubMed ID: 27000110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
